abrdn Life Sciences Investors
(NYSE:HQL)
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have significant potential for above-average growth.
top performing HQL trades
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent abrdn Life Sciences trades made by congress members.
Thomas R. CarperSenate (D-DE) | $1K - $15K | stock | Sale | Nov 03, 2022 | Oct 04, 2022 | Senate |